Image_1_Case Report: Difficulties in the Treatment of a 12-Year-Old Patient With Homozygous Familial Hypercholesterolemia, Compound Heterozygous Form − 5 Years Follow-Up.JPEG by Lyudmila Vladimirova-Kitova (11537353)

“…Initial treatment, based on European recommendations, included Atorvastatin 20 mg and Ezetimibe 10 mg and led to a decrease in LDL-C by 46% for 5 months; however, the patient developed severe statin intolerance. …”

DataSheet_1_DNA N6-Methyladenine (6mA) Modification Regulates Drug Resistance in Triple Negative Breast Cancer.pdf by Xianneng Sheng (10076839)

Image_5_Guizhi Fuling Wan, Chinese Herbal Medicine, Ameliorates Insulin Sensitivity in PCOS Model Rats With Insulin Resistance via Remodeling Intestinal Homeostasis.PNG by Ying Zhu (90057)

Enhanced Reaction Kinetics in Stationary Two-Phase Flow through Porous Media by Xueyi Zhang (2019148)

The infected silkworm ovarioles on the fifth day of pupation. by Chunxia Wang (766713)

<i>N</i>. <i>bombycis</i> bound with BmVg domains VWD and DUF1943. by Chunxia Wang (766713)

Chemical composition of the surface layer of the original cork and of the cork samples after outdoor exposure and soil burial, regarding extractives soluble in dichloromethane (DCM... by Isabel Miranda (8055)

Characterization of recent and minimally passaged Brazilian dengue viruses inducing robust infection in rhesus macaques by Maria Beatriz Borges (5142965)

Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects by Jie Zhou (28945)

“…In this work, a series of novel benzamide derivatives were designed and synthesized as Kv2.1 inhibitors, and extensive structure–activity relationships led to highly potent and selective Kv2.1 inhibitors having IC₅₀ values of 10^–8 M. …”

Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects by Jie Zhou (28945)

“…In this work, a series of novel benzamide derivatives were designed and synthesized as Kv2.1 inhibitors, and extensive structure–activity relationships led to highly potent and selective Kv2.1 inhibitors having IC₅₀ values of 10^–8 M. …”

Discovery of 2‑Ethoxy-5-isobutyramido‑<i>N</i>‑1-substituted Benzamide Derivatives as Selective Kv2.1 Inhibitors with In Vivo Neuroprotective Effects by Jie Zhou (28945)

“…In this work, a series of novel benzamide derivatives were designed and synthesized as Kv2.1 inhibitors, and extensive structure–activity relationships led to highly potent and selective Kv2.1 inhibitors having IC₅₀ values of 10^–8 M. …”

Body weight and lung immune cell population measurements following cellular ablation of lung pulmonary vagal afferents with AAVrg^{mCh FLEX DTA} in mock-infected Phox2B-Cre... by Nathalie A. J. Verzele (18389733)

Body weight, clinical score, lung pathology, lung cytokine and lung immune cell population measurements in QX-314 and vehicle treated mice following mock infection. by Nathalie A. J. Verzele (18389733)

S5 File - by Marian Adan (16641634)

S3 File - by Marian Adan (16641634)

S1 File - by Marian Adan (16641634)

S6 File - by Marian Adan (16641634)

S2 File - by Marian Adan (16641634)

S4 File - by Marian Adan (16641634)

Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA₂), UCM-14216, Ameliorates Spinal Cord Injury in Mice by Nora Khiar-Fernández (8130210)

“…Inhibition of the type 2 lysophosphatidic acid receptor (LPA₂) has recently emerged as a new potential pharmacological approach to decrease SCI-associated damage. …”